AR

Aravind Reddy Avula

Active Director Director DIN 11215792
DIN 11215792 First appointment Jul 2025 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Aravind Reddy Avula

Data last updated:

Aravind Reddy Avula is a Director at Agarino Healthcare Private Limited (since 2025). The company operates in Information Technology.

DIN 11215792
Primary Designation Director
Industry Information Technology
First Appointment 26 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Agarino Healthcare Private Limited U62090TS2025PTC201580
Director26 Jul 20252025Active

Board colleagues of Aravind Reddy Avula

NameDINCompanyDesignation
Jahnavi Yakkanti11215793Agarino Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Agarino Healthcare Private Limited
Premium access

Shareholding and investment profile for Aravind Reddy Avula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aravind Reddy Avula

Aravind Reddy Avula currently holds 1 directorship: Agarino Healthcare Private Limited (Director, since 26 Jul 2025).

Aravind Reddy Avula was first appointed on 26 Jul 2025 as Director at Agarino Healthcare Private Limited.

The current boards of Aravind Reddy Avula's companies include Jahnavi Yakkanti (Agarino Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available